Agile Therapeutics, Inc.

500 College Road East, Suite 310

Princeton, New Jersey 08540

 

May 19, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549

 

Re: Agile Therapeutics, Inc.

Registration Statement on Form S-1

File No. 333-271249

Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Agile Therapeutics, Inc. (the “Company”) hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 (as amended, the “Registration Statement”) be accelerated to Monday, May 22, 2023, at 3:00 p.m., Eastern Time, or as soon as thereafter practicable.

 

Once the Registration Statement has been declared effective, please orally confirm that event with Bryan S. Keighery of Morgan, Lewis & Bockius LLP at (617) 341-7269.

 

Thank you very much.

 

	Very truly yours,
	Agile Therapeutics, Inc.
	By:	/s/ Alfred Altomari
	Name:	Alfred Altomari
	Title:	Chief Executive Officer